Evidence map›Paper›PMID 26762983›Full record

ArticleNucleic acids research2016

An essential role for UTX in resolution and activation of bivalent promoters.

Shilpa S Dhar, Sung-Hun Lee, Kaifu Chen, Guangjing Zhu, WonKyung Oh, Kendra Allton, Ohad Gafni, Young Zoon Kim, Alin S Tomoiga, Michelle Craig Barton and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. UTX (KDM6A) promotes differentiation noncatalytically in somatic self-renewing epithelia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. MLL3 regulates theeLife · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Shilpa S DharDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sung-Hun LeeDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kaifu ChenInstitute for Academic Medicine, The Methodist Hospital Research Institute, Houston, TX 77030, USA Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, The Methodist Hospital Research Institute, Houston, TX 77030, USA Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
Guangjing ZhuDepartment of Environmental Health Sciences, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD 21205, USA.
WonKyung OhDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kendra AlltonDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ohad GafniThe Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Young Zoon KimDivision of Neurooncology and Department of Neurosurgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 158, Paryong-ro, Masan Hoiwon-Gu, Changwon, Gyeongsangnam-do, 630-723, Korea.
Alin S TomoigaInstitute for Academic Medicine, The Methodist Hospital Research Institute, Houston, TX 77030, USA Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, The Methodist Hospital Research Institute, Houston, TX 77030, USA Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
Michelle Craig BartonDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Genes and Development Graduate Program, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA.
Jacob H HannaThe Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Zhibin WangDepartment of Environmental Health Sciences, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD 21205, USA zwang47@jhu.edu.
Wei LiDivision of Biostatistics, Dan L. Duncan Cancer Center and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA WL1@bcm.edu.
Min Gyu LeeDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Cancer Biology Program,The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA mglee@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USJohns Hopkins University · USWeizmann Institute of Science · ILBaylor College of Medicine · USCornell University · USHouston Methodist · USSungkyunkwan University · KR

Funding

Computational and Experimental Modeling of Epigenetic DNA MethylationR01HG007538 · NHGRI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LI, WEI · 2014 to 2018
$1.9M
Exposure-altered gene expression in five candidate imprinted loci for adult diseaseR01ES025761 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI WANG, ZHIBIN · 2016 to 2020
$1.5M
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate CancerR01CA157919 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LEE, MIN GYU · 2011 to 2015
$1.5M
Role of the Histone Modifier KDM6A in Stem Cell DifferentiationR01GM095659 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LEE, MIN GYU · 2011 to 2014
$1.2M
NCI NIH HHS R01 CA157919NHGRI NIH HHS R01 HG007538NIEHS NIH HHS R01 ES025761NIGMS NIH HHS R01 GM095659
6 · The paper itself

Abstract

Trimethylated histone H3 lysine 27 (H3K27me3) is linked to gene silencing, whereas H3K4me3 is associated with gene activation. These two marks frequently co-occupy gene promoters, forming bivalent domains. Bivalency signifies repressed but activatable states of gene expression and can be resolved to active, H3K4me3-prevalent states during multiple cellular processes, including differentiation, development and epithelial mesenchymal transition. However, the molecular mechanism underlying bivalency resolution remains largely unknown. Here, we show that the H3K27 demethylase UTX (also called KDM6A) is required for the resolution and activation of numerous retinoic acid (RA)-inducible bivalent genes during the RA-driven differentiation of mouse embryonic stem cells (ESCs). Notably, UTX loss in mouse ESCs inhibited the RA-driven bivalency resolution and activation of most developmentally critical homeobox (Hox) a-d genes. The UTX-mediated resolution and activation of many bivalent Hox genes during mouse ESC differentiation were recapitulated during RA-driven differentiation of human NT2/D1 embryonal carcinoma cells. In support of the importance of UTX in bivalency resolution, Utx-null mouse ESCs and UTX-depleted NT2/D1 cells displayed defects in RA-driven cellular differentiation. Our results define UTX as a bivalency-resolving histone modifier necessary for stem cell differentiation.

Indexed as

Promoter Regions, GeneticTranscriptional ActivationAnimalsCell DifferentiationCell Line, TumorCells, CulturedEmbryonic Stem CellsGenes, HomeoboxHistone DemethylasesHumansMiceNuclear ProteinsTretinoinHistone DemethylasesKDM6A protein, humanNuclear ProteinsTretinoinUtx protein, mouse

Identifiers

PMID26762983
PMCPMC4856969
OpenAlexW2239846723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.